Benigne og maligne neoplasmatiske lidelser inklusiv EBV- associerede lymfoproliferative lidelser og maligne tilstande i huden er blevet rapporteret.
Benign as well as malignant neoplasms including EBV-associated lymphoproliferative disorders and skin malignancies have been reported in association with tacrolimus treatment.